Compounds > pyrroles
Page last updated: 2024-08-18

pyrroles and Tachycardia, Ventricular

pyrroles has been researched along with Tachycardia, Ventricular in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asrar Ul Haq, M; Mutha, V; Rudd, N; Subiakto, I; Van Gaal, WJ1
Ghais, NS; Grace, AA; Huang, CL; Zhang, Y1
He, XZ; Wan, XH; Wang, HY; Xue, JF; Zhong, QH; Zhou, SH2
Chedgy, F; Howlett, DC; Inglis, C1
Bernard, D; De Backer, G; De Bacquer, D; De Buyzere, M; De Sutter, J; Jordaens, L; Langlois, M; Matthys, K; Tavernier, R; Van de Veire, NR1
De Groot, SH; Gorgels, AP; Leunissen, JD; Lipcsei, GC; Vos, MA; Wellens, HJ1
Hellegouarch, A; Tosaki, A1

Trials

4 trial(s) available for pyrroles and Tachycardia, Ventricular

ArticleYear
Use of ivabradine and atorvastatin in emergent orthopedic lower limb surgery and computed tomography coronary plaque imaging and novel biomarkers of cardiovascular stress and lipid metabolism for the study and prevention of perioperative myocardial infarc
    Trials, 2014, Sep-07, Volume: 15

    Topics: Anti-Arrhythmia Agents; Atorvastatin; Benzazepines; Biomarkers; Clinical Protocols; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Emergencies; Femoral Neck Fractures; Heart Rate; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ivabradine; Middle Aged; Myocardial Infarction; Orthopedic Procedures; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Pyrroles; Research Design; Risk Factors; Severity of Illness Index; Tachycardia, Ventricular; Tomography, X-Ray Computed; Treatment Outcome; Victoria

2014
The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome.
    Cardiology journal, 2010, Volume: 17, Issue:4

    Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Chi-Square Distribution; China; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk Assessment; Risk Factors; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes

2010
The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome.
    Clinical cardiology, 2011, Volume: 34, Issue:1

    Topics: Acute Coronary Syndrome; Aged; Anti-Arrhythmia Agents; Atorvastatin; Chi-Square Distribution; China; Double-Blind Method; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Risk Assessment; Risk Factors; Tachycardia, Ventricular; Time Factors; Treatment Outcome; Ventricular Premature Complexes

2011
Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants.
    International journal of cardiology, 2006, Sep-10, Volume: 112, Issue:1

    Topics: Adult; Aged; Anticholesteremic Agents; Atorvastatin; Belgium; Biomarkers; C-Reactive Protein; Coronary Artery Disease; Defibrillators, Implantable; Double-Blind Method; Female; Follow-Up Studies; Glycated Hemoglobin; Greece; Heptanoic Acids; Humans; Inflammation; Inflammation Mediators; Lipids; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Prevalence; Pyrroles; Research Design; Risk Factors; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation

2006

Other Studies

4 other study(ies) available for pyrroles and Tachycardia, Ventricular

ArticleYear
Arrhythmogenic actions of the Ca2+ channel agonist FPL-64716 in Langendorff-perfused murine hearts.
    Experimental physiology, 2009, Volume: 94, Issue:2

    Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Diltiazem; Disease Models, Animal; Electric Stimulation; Heart; Homeostasis; Indoles; Mice; Mice, Inbred Strains; Myocytes, Cardiac; Nifedipine; Pyrroles; Sarcoplasmic Reticulum; Tachycardia, Ventricular

2009
A case of recurrent ventricular tachycardia.
    BMJ (Clinical research ed.), 2011, Jun-01, Volume: 342

    Topics: Aged; Atorvastatin; Cardiovascular Agents; Digoxin; Drug Therapy, Combination; Female; Furosemide; Heptanoic Acids; Humans; Isosorbide Dinitrate; Lisinopril; Nitroglycerin; Pyrroles; Recurrence; Tachycardia, Ventricular; Warfarin

2011
Mechanism-specific antiarrhythmic effects of the potassium channel activator levcromakalim against repolarization-dependent tachycardias.
    Journal of cardiovascular electrophysiology, 1994, Volume: 5, Issue:9

    Topics: Animals; Anti-Arrhythmia Agents; Benzopyrans; Cromakalim; Dogs; Electrocardiography; Female; Heart; Heart Block; Hemodynamics; Male; Ouabain; Pyrroles; Tachycardia, Ventricular; Torsades de Pointes

1994
Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischemia/reperfusion-induced injury. Heart function studies in nonfibrillating isolated hearts.
    Journal of the American College of Cardiology, 1994, Volume: 23, Issue:2

    Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzopyrans; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Guinea Pigs; Magnetic Resonance Spectroscopy; Male; Myocardial Reperfusion Injury; Myocardium; Potassium Channels; Pyrroles; Tachycardia, Ventricular; Ventricular Fibrillation

1994